Pim-1 kinase inhibits the activation of reporter gene expression in Elk-1 and c-Fos reporting systems but not the endogenous gene expression: An artifact of the reporter gene assay by transient co-transfection

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 2, 2006, Pages 169-176

  Yan, B ^a   Wang, H ^a   Kon, T ^a   Li, C Y ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Elk 1; Mitogen activated protein kinase pathway; Pim 1 kinase; Reporter assay; Signal transduction

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ARTIFACT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NONHUMAN; NORTHERN BLOTTING; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALIA;

EID: 33646176827     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000200002     Document Type: Article

References (30)

1. Saris CJ, Domen J & Berns A (1991). The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO Journal, 10: 655-664.
2. Hoover D, Friedmann M, Reeves R et al. (1991). Recombinant human pim-1 protein exhibits serine/threonine kinase activity. Journal of Biological Chemistry, 266: 14018-14023.
3. Padma R & Nagarajan L (1991). The human PIM-1 gene product is a protein serine kinase. Cancer Research, 51: 2486-2489.
4. Breuer M, Wientjens E, Verbeek S et al. (1991). Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Research, 51: 958-963.
5. van Lohuizen M, Verbeek S, Krimpenfort P et al. (1989). Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56: 673-682.
6. Allen JD & Berns A (1996). Complementation tagging of cooperating oncogenes in knockout mice. Seminars in Cancer Biology, 7: 299-306.
7. Yen B, Zemskova M, Holder S et al. (2003). The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. Journal of Biological Chemistry, 278: 45358-45367.
8. Moroy T, Grzeschiczek A, Petzold S et al. (1993). Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/ lpr mice. Proceedings of the National Academy of Sciences, USA, 90: 10734-10738.
9. Lilly M & Kraft A (1997). Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Research, 57: 5348-5355.
10. Pircher TJ, Zhao S, Geiger JN et al. (2000). Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene, 19: 3684-3692.
11. Wang Z, Bhattacharya N, Weaver M et al. (2001). Pim-1: a serine/ threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. Journal of Veterinarian Science, 2: 167-179.
12. Maita H, Harada Y, Nagakubo D et al. (2000). PAP-1, a novel target protein of phosphorylation by pim-1 kinase. European Journal of Biochemistry, 267: 5168-5178.
13. Ishibashi Y, Maita H, Yano M et al. (2001). Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus. FEBS Letters, 506: 33-38.
14. Leduc I, Karsunky H, Mathieu N et al. (2000). The Pim-1 kinase stimulates maturation of TCRbeta-deficient T cell progenitors: implications for the mechanism of Pim-1 action. International Immunology, 12: 1389-1396.
15. Leverson JD, Koskinen PJ, Orrico FC et al. (1998). Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Molecular Cell, 2: 417-425.
16. Lilly M, Sandholm J, Cooper JJ et al. (1999). The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene, 18: 4022-4031.
17. Rainio EM, Sandholm J & Koskinen PJ (2002). Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. Journal of Immunology, 168: 1524-1527.
18. Kyriakis JM, App H, Zhang XF et al. (1992). Raf-1 activates MAP kinase-kinase. Nature, 358: 417-421.
19. Dent P, Haser W, Haystead TA et al. (1992). Activation of mitogenactivated protein kinase by v-Raf in NIH 3T3 cells and in vitro. Science, 257: 1404-1407.
20. Haccard O, Sarcevic B, Lewellyn A et al. (1993). Induction of metaphase arrest in cleaving Xenopus embryos by MAP kinase. Science, 262: 1262-1265.
21. Posada J, Yew N, Ahn NG et al. (1993). Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Molecular and Cellular Biology, 13: 2546-2553.
22. Salmeron A, Ahmad TB, Carlile GW et al. (1996). Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase. EMBO Journal, 15: 817-826.
23. Ghoda L, Lin X & Greene WC (1997). The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of lkappaBalpha and stimulates its degradation in vitro. Journal of Biological Chemistry, 272: 21281-21288.
24. Janknecht R, Ernst WH, Pingoud V et al. (1993). Activation of ternary complex factor Elk-1 by MAP kinases. EMBO Journal, 12: 5097-5104.
25. Hussain S, Zwilling BS & Lafuse WP (1999). Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor. Journal of Immunology, 163: 2041-2048.
26. Kortenjann M, Thomae O & Shaw PE (1994). Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Molecular and Cellular Biology, 14: 4815-4824.
27. Marais R, Wynne J & Treisman R (1993). The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell, 73: 381-393.
28. Gille H, Sharrocks AD & Shaw PE (1992). Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature, 358: 414-417.
29. Hill CS & Treisman R (1995). Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO Journal, 14: 5037-5047.
30. Chattopadhyay S, Whitehurst CE & Chen J (1998). A nuclear matrix attachment region upstream of the T cell receptor beta gene enhancer binds Cux/CDP and SATB1 and modulates enhancer-dependent reporter gene expression but not endogenous gene expression. Journal of Biological Chemistry, 273: 29838-29846.